Rosuvastatin alleviates high-salt and cholesterol diet-induced cognitive impairment in rats via Nrf2-ARE pathway.
Ibraheem HusainMohd AkhtarTushar MadaanMalik Zainul AbdinMohammad IslamuddinAbul Kalam NajmiPublished in: Redox report : communications in free radical research (2018)
We have investigated a novel mechanism of action for rosuvastatin (via the Nrf2-ARE pathway) and demonstrated that it has the potential to be used in the treatment of cognitive impairment.